827 related articles for article (PubMed ID: 22441299)
1. Functionalized mesoporous silica materials for controlled drug delivery.
Yang P; Gai S; Lin J
Chem Soc Rev; 2012 May; 41(9):3679-98. PubMed ID: 22441299
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery from ordered mesoporous matrices.
Manzano M; Colilla M; Vallet-Regí M
Expert Opin Drug Deliv; 2009 Dec; 6(12):1383-400. PubMed ID: 19941412
[TBL] [Abstract][Full Text] [Related]
4. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers.
Popat A; Hartono SB; Stahr F; Liu J; Qiao SZ; Qing Max Lu G
Nanoscale; 2011 Jul; 3(7):2801-18. PubMed ID: 21547299
[TBL] [Abstract][Full Text] [Related]
5. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.
Zhao Y; Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Expert Opin Drug Deliv; 2010 Sep; 7(9):1013-29. PubMed ID: 20716017
[TBL] [Abstract][Full Text] [Related]
6. Mesoporous silica nanoparticles as nanocarriers.
Wu SH; Hung Y; Mou CY
Chem Commun (Camb); 2011 Sep; 47(36):9972-85. PubMed ID: 21716992
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.
Rosenholm JM; Mamaeva V; Sahlgren C; Lindén M
Nanomedicine (Lond); 2012 Jan; 7(1):111-20. PubMed ID: 22191780
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous materials for drug delivery.
Vallet-Regí M; Balas F; Arcos D
Angew Chem Int Ed Engl; 2007; 46(40):7548-58. PubMed ID: 17854012
[TBL] [Abstract][Full Text] [Related]
9. Silicon-polymer hybrid materials for drug delivery.
McInnes SJ; Voelcker NH
Future Med Chem; 2009 Sep; 1(6):1051-74. PubMed ID: 21425994
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of oxygen-deficient luminescent mesoporous silica nanoparticles for synchronous drug delivery and imaging.
He Q; Shi J; Cui X; Wei C; Zhang L; Wu W; Bu W; Chen H; Wu H
Chem Commun (Camb); 2011 Jul; 47(28):7947-9. PubMed ID: 21499640
[TBL] [Abstract][Full Text] [Related]
11. [Mesoporous silica nanoparticles for cancer theranostic drug delivery].
Wang X; Teng ZG; Huang XY; Lu GM
Yao Xue Xue Bao; 2013 Jan; 48(1):8-13. PubMed ID: 23600135
[TBL] [Abstract][Full Text] [Related]
12. pH-operated nanopistons on the surfaces of mesoporous silica nanoparticles.
Zhao YL; Li Z; Kabehie S; Botros YY; Stoddart JF; Zink JI
J Am Chem Soc; 2010 Sep; 132(37):13016-25. PubMed ID: 20799689
[TBL] [Abstract][Full Text] [Related]
13. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
14. pH-responsive controlled release of antitumour-active polyoxometalate from mesoporous silica materials.
Sun G; Chang Y; Li S; Li Q; Xu R; Gu J; Wang E
Dalton Trans; 2009 Jun; (23):4481-7. PubMed ID: 19488446
[TBL] [Abstract][Full Text] [Related]
15. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.
Slowing II; Vivero-Escoto JL; Wu CW; Lin VS
Adv Drug Deliv Rev; 2008 Aug; 60(11):1278-1288. PubMed ID: 18514969
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems.
Giri S; Trewyn BG; Lin VS
Nanomedicine (Lond); 2007 Feb; 2(1):99-111. PubMed ID: 17716196
[TBL] [Abstract][Full Text] [Related]
17. Luminescent GdVO4:Eu3+ functionalized mesoporous silica nanoparticles for magnetic resonance imaging and drug delivery.
Huang S; Cheng Z; Ma P; Kang X; Dai Y; Lin J
Dalton Trans; 2013 May; 42(18):6523-30. PubMed ID: 23474744
[TBL] [Abstract][Full Text] [Related]
18. Control of drug release through the in situ assembly of stimuli-responsive ordered mesoporous silica with magnetic particles.
Zhu S; Zhou Z; Zhang D
Chemphyschem; 2007 Dec; 8(17):2478-83. PubMed ID: 17952885
[TBL] [Abstract][Full Text] [Related]
19. Applications of mesoporous materials as excipients for innovative drug delivery and formulation.
Shen SC; Ng WK; Chia LS; Dong YC; Tan RB
Curr Pharm Des; 2013; 19(35):6270-89. PubMed ID: 23470004
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous silica functionalized with an AIE luminogen for drug delivery.
Li D; Yu J; Xu R
Chem Commun (Camb); 2011 Oct; 47(39):11077-9. PubMed ID: 21897920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
